Previous close | 130.76 |
Open | 130.17 |
Bid | 0.00 x 3200 |
Ask | 0.00 x 800 |
Day's range | 130.15 - 131.60 |
52-week range | 99.14 - 133.10 |
Volume | |
Avg. volume | 8,222,070 |
Market cap | 332.051B |
Beta (5Y monthly) | 0.40 |
PE ratio (TTM) | 145.67 |
EPS (TTM) | 0.90 |
Earnings date | 30 Jul 2024 |
Forward dividend & yield | 3.08 (2.35%) |
Ex-dividend date | 14 Mar 2024 |
1y target est | 141.42 |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Key Insights Institutions' substantial holdings in Merck implies that they have significant influence over the...
Merck (MRK) stock is being driven by the strong sales of key products like Keytruda and Gardasil and positive pipeline and regulatory developments.